Annual CFO
-$188.16 M
-$34.51 M-22.46%
31 December 2023
Summary:
Dyne Therapeutics annual cash flow from operations is currently -$188.16 million, with the most recent change of -$34.51 million (-22.46%) on 31 December 2023. During the last 3 years, it has fallen by -$141.65 million (-304.57%). DYN annual CFO is now -4418.68% below its all-time high of -$4.16 million, reached on 31 December 2018.DYN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$74.63 M
-$19.76 M-36.02%
30 September 2024
Summary:
Dyne Therapeutics quarterly cash flow from operations is currently -$74.63 million, with the most recent change of -$19.76 million (-36.02%) on 30 September 2024. Over the past year, it has dropped by -$24.03 million (-47.48%). DYN quarterly CFO is now -924.00% below its all-time high of -$7.29 million, reached on 31 March 2020.DYN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$243.04 M
-$24.03 M-10.97%
30 September 2024
Summary:
Dyne Therapeutics TTM cash flow from operations is currently -$243.04 million, with the most recent change of -$24.03 million (-10.97%) on 30 September 2024. Over the past year, it has dropped by -$60.70 million (-33.29%). DYN TTM CFO is now -3234.80% below its all-time high of -$7.29 million, reached on 31 March 2020.DYN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.5% | -47.5% | -33.3% |
| 3 y3 years | -304.6% | -176.9% | -117.9% |
| 5 y5 years | -4418.7% | - | - |
DYN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -304.6% | at low | -176.9% | +5.0% | -117.9% | at low |
| 5 y | 5 years | -4418.7% | at low | -924.0% | +5.0% | -3234.8% | at low |
| alltime | all time | -4418.7% | at low | -924.0% | +5.0% | -3234.8% | at low |
Dyne Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$74.63 M(+36.0%) | -$243.04 M(+11.0%) |
| June 2024 | - | -$54.87 M(-30.1%) | -$219.01 M(-0.4%) |
| Mar 2024 | - | -$78.54 M(+124.4%) | -$219.79 M(+16.8%) |
| Dec 2023 | -$188.16 M(+22.5%) | -$35.01 M(-30.8%) | -$188.16 M(+3.2%) |
| Sept 2023 | - | -$50.60 M(-9.1%) | -$182.34 M(+4.5%) |
| June 2023 | - | -$55.64 M(+18.6%) | -$174.55 M(+16.5%) |
| Mar 2023 | - | -$46.91 M(+60.7%) | -$149.81 M(-2.5%) |
| Dec 2022 | -$153.65 M | -$29.19 M(-31.8%) | -$153.65 M(+0.7%) |
| Sept 2022 | - | -$42.80 M(+38.5%) | -$152.52 M(+11.6%) |
| June 2022 | - | -$30.91 M(-39.1%) | -$136.67 M(-10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$50.74 M(+80.8%) | -$151.91 M(+27.1%) |
| Dec 2021 | -$119.56 M(+157.1%) | -$28.07 M(+4.1%) | -$119.56 M(+7.2%) |
| Sept 2021 | - | -$26.95 M(-41.6%) | -$111.53 M(+15.6%) |
| June 2021 | - | -$46.15 M(+150.9%) | -$96.47 M(+67.4%) |
| Mar 2021 | - | -$18.39 M(-8.2%) | -$57.61 M(+23.9%) |
| Dec 2020 | -$46.51 M(+293.0%) | -$20.04 M(+68.6%) | -$46.51 M(+75.7%) |
| Sept 2020 | - | -$11.89 M(+62.9%) | -$26.47 M(+81.5%) |
| June 2020 | - | -$7.30 M(+0.1%) | -$14.59 M(+100.1%) |
| Mar 2020 | - | -$7.29 M | -$7.29 M |
| Dec 2019 | -$11.83 M(+184.2%) | - | - |
| Dec 2018 | -$4.16 M | - | - |
FAQ
- What is Dyne Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Dyne Therapeutics?
- What is Dyne Therapeutics annual CFO year-on-year change?
- What is Dyne Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly CFO year-on-year change?
- What is Dyne Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Dyne Therapeutics?
- What is Dyne Therapeutics TTM CFO year-on-year change?
What is Dyne Therapeutics annual cash flow from operations?
The current annual CFO of DYN is -$188.16 M
What is the all time high annual CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash flow from operations is -$4.16 M
What is Dyne Therapeutics annual CFO year-on-year change?
Over the past year, DYN annual cash flow from operations has changed by -$34.51 M (-22.46%)
What is Dyne Therapeutics quarterly cash flow from operations?
The current quarterly CFO of DYN is -$74.63 M
What is the all time high quarterly CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash flow from operations is -$7.29 M
What is Dyne Therapeutics quarterly CFO year-on-year change?
Over the past year, DYN quarterly cash flow from operations has changed by -$24.03 M (-47.48%)
What is Dyne Therapeutics TTM cash flow from operations?
The current TTM CFO of DYN is -$243.04 M
What is the all time high TTM CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM cash flow from operations is -$7.29 M
What is Dyne Therapeutics TTM CFO year-on-year change?
Over the past year, DYN TTM cash flow from operations has changed by -$60.70 M (-33.29%)